Introduction {#S1}
============

*Pseudomonas aeruginosa* is one of the important causes of hospital-acquired infections in intensive care unit (ICU) and considered as a major determinant of morbidity and mortality in patients affected by cystic fibrosis (CF) \[[@R01]-[@R03]\].

Surveillance of nosocomial *P. aeruginosa* infections has revealed trends of increasing antimicrobial resistance \[[@R04]\]. The emergence of transmissible *P. aeruginosa* strains at hospital and its spread to other *P. aeruginosa-*negative patients raise concerns especially in ICU settings, where the number of antibiotic agents with good activity is limited \[[@R05], [@R06]\]. Several studies describe the patient- to-patient transmission of this bacteria from centers related with CF patients \[[@R07], [@R08]\].

At our hospital, CF patients are cared in gastroenterology ward and *P. aeruginosa*-positive and *P. aeruginosa*- negative patients are not separated from each other in this ward. In addition, these patients move to other wards especially ICU during their hospitalization. The aim of this study was to investigate epidemiology of antimicrobial resistance and clonal diversity among randomly picked *P. aeruginosa* isolates of CF and the other hospitalized patients in ICU.

Material and methods {#S2}
====================

Between January and December 2010, randomly picked *P. aeruginosa* isolates of infected patient in ICU and patients affected by CF were collected from the tertiary referral Children Medical Hospital in Tehran, Iran. The patients investigated in this study were all prone to *P. aeruginosa* infection. An infected patient was defined as a patient with clinical symptoms of infection, and from whom a clinical culture yielded a dominant growth of *P.aeruginosa*. Clinical information on *P. aeruginosa* patient isolates was collected from medical records. Information included age, sex, length of hospital stay, history of transfer from another wards, clinical outcome and microbiological data.

A number of CF patients had more than one isolates and some of them were isolated while they were transferred to the ICU. In addition several cultures were obtained from some patients as long as they stayed in the ICU. Cultivation, identification, and antimicrobial susceptibility testing of *P. aeruginosa* isolates were performed using standard techniques \[[@R09]\].

Multi-resistant *P. aeruginosa* (MRPA) was defined as strains resistant to ≥ 3 of the following classes of antibiotics: antipseudomonal penicillins, antipseudomonal oxyimino- b-lactams, fluoroquinolones, aminoglycosides, and carbapenems \[[@R10]\].

The genetic similarity of the strains was investigated by amplification of the Enterobacterial Repetitive Intergenic Consensus-polymerase chain reaction (ERIC-PCR). sequence \[[@R11]\]. Comparison of banding patterns was performed using Gelcompar II, version 6.5 (Applied Maths, Sint-Matens-latem, Belgium). Cluster analysis was accomplished with the unweighted pair group method using average linkages (UPGMA). ERIC-PCR was performed for *P. aeruginosa* isolates and relatedness among genetic clones was defined as 80% similarity as belonging to one clone.

Results {#S3}
=======

During one year, 36 patients aged 3.5 to 192 month (average 33.4) were entered to this study. [Table I](#T1){ref-type="table"} illustrated the patient details, origin and date of isolation, outcome, ERIC-PCR and antibiogram pattern of all isolates.

###### 

Patient details, origin and date of isolation, outcome and microbiological data of all the *P. aeruginosa* isolates.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient[^\*^](#T1FN1){ref-type="table-fn"}   Isolates   Age\      Gender             Ward                Type of specimen    Length of hospital stay(Day)   Time of isolation after hospitalization(Day)   Outcome     ERIC-PCR pattern   Antibiogram pattern
                                                          (month)                                                                                                                                                                           
  -------------------------------------------- ---------- --------- ------------------ ------------------- ------------------- ------------------------------ ---------------------------------------------- ----------- ------------------ ---------------------
  1                                            a          11        M                  PICU                Trachea tube        21                             4                                              Death       D                  12

  2                                            a          12        M                  PICU                Wound               30                             6                                              Discharge   B                  3

  3                                            a          12        F                  PICU                Ear secretion       58                             5                                              Discharge   C                  15

  4                                            a          7         M                  PICU                Trachea tube        34                             20                                             Discharge   E                  11

  5                                            a          2.5       F                  PICU                Urine               29                             2                                              Discharge   C                  15

  6                                            a          10        F                  PICU                Urine               30                             21                                             Death       C                  15

  7                                            a          6         F                  PICU                Wound               11                             10                                             Death       A                  6

  8                                            a          3         M                  PICU                Urine               21                             5                                              Death       B                  7

  9                                            a          11        F                  PICU                Trachea tube        5                              2                                              Discharge   B                  8

  10                                           a          3         F                  PICU                Wound               22                             12                                             Death       B                  7

  b                                                                                    Eye                                     22                                                                            B           4                  

  11                                           a          7         F                  PICU                Trachea tube        15                             5                                              Discharge   B                  4

  12                                           a          120       M                  PICU                Urine               13                             2                                              Discharge   B                  3

  13                                           a          2         M                  PICU                Trachea tube        5                              3                                              Death       B                  11

  14                                           a          9         M                  PICU                Trachea tube        39                             4                                              Discharge   B                  4

  b                                                                                    Wound                                   17                                                                            B           3                  

  15                                           a          108       F                  PICU                Trachea tube        54                             2                                              Discharge   B                  2

  16                                           a          24        M                  PICU                Trachea tube        4                              3                                              Discharge   A                  7

  17                                           a          4         F                  PICU                Blood               28                             4                                                          E                  10

  b                                                                                    Alveolar aspirate                       14                             Discharge                                      A           3                  

  c                                                                                    Sputum                                  8                                                                             A           3                  

  d                                                                                    Alveolar aspirate                       8                                                                             C           12                 

  18                                           a          8         M                  PICU                Trachea tube        18                             2                                              Discharge   C                  2

  b                                                                                    Urine                                   14                                                                            C           1                  

  19                                           a          36        F                  PICU                Wound               40                             3                                              Discharge   B                  7

  b                                                       F                                                                    5                                                                             C           14                 

  c                                                       F                                                                    20                                                                            C           12                 

  20                                           a          4         M                  PICU                Urine               25                             1                                              Discharge   C                  15

  21                                           a          31        F                  PICU                Urine               26                             5                                              Discharge   B                  3

  22                                           a          36        M                  PICU                Blood               58                             1                                              Discharge   C                  15

  23                                           a          120       M                  PICU                Trachea tube        19                             4                                              Discharge   B                  3

  24                                           a          24        M                  PICU                Pharynx             15                             6                                              Discharge   C                  14

  25                                           a          3         F                  PICU                Wound               51                             3                                              Death       C                  15

  26                                           a          12        F                  PICU                Wound               14                             14                                             Death       C                  15

  27                                           a          192       F                  Gastroenterology    Alveolar aspirate   56                             4                                              Death       B                  6

  b                                                                 Gastroenterology   Sputum                                  40                                                                            B           7                  

  c                                                                 Gastroenterology   Sputum                                  46                                                                            B           6                  

  28                                           a          72        M                  PICU                Trachea tube        12                             2                                              Death       B                  5

  b                                                                 PICU               Tracheal aspirate                       7                                                                             B           13                 

  c                                                                 PICU               Trachea tube                            11                                                                            B           11                 

  29                                           a          5         F                  PICU                Sputum              10                             1                                              Dischage    C                  15

  30                                           a          45        M                  Gastroenterology    Sputum              14                             2                                              Dischage    B                  8

  31                                           a          120       M                  Gastroenterology    Sputum              12                             2                                              Death       B                  7

  32                                           a          10        M                  PICU                Wound               10                             9                                              Death       C                  15

  33                                           a          5         F                  Gastroenterology    Urine               11                             1                                              Dischage    B                  9

  34                                           a          7         M                  Gastroenterology    Urine               36                             2                                              Death       C                  15

  35                                           a          72        M                  PICU                Trachea tube        7                              2                                              Death       B                  3

  b                                                                 Gastroenterology   Sputum              7                   7                                                                             C           15                 

  36                                           a          48        F                  Gastroenterology    Sputum                                             1                                              Dischage    B                  10
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Isolates number of 26 to 36 isolated from CF patients. PICU: Pediatric Intensive Care Unit

Among 49 isolates, sixteen were isolated from 11 patients affected by CF and 33 came from an epidemiological investigation of 25 *P. aeruginosa* strains isolated from infected patients of ICU.

*P. aeruginosa* isolates were recovered from trachea tube (26%), urine (18%), wound (16%), sputum (18%), alveolar aspirate (8%), blood (4%), tracheal aspirate (2%), ear secretion (2%), and eye (2%).

Average length of hospital stay in all patients was 24 days. Of the 36 patients, 14 died during the study (case fatality rate, 39%); whereas half of them were from CF patients (case fatality rate, 64%). MRPA were identified in 23 isolates (47%) and consistently detected during the study period. Among all isolates, 11 considered as panresistant isolates that 5 of them belonged to CF patients. Five clusters were generated for all isolates analyzed through ERIC-PCR genotyping, which were designated alphabetically from A to D ([Fig. 1](#F1){ref-type="fig"}). Cluster B and C comprised both ICU and CF isolates while cluster A, D and E had only isolates of ICU ward. Eleven isolates of cluster B were identical whereas cluster C comprised of only 3 identical isolates.

![Dendrogram of genotype analysis derived from 49 *P. aeruginosa* isolates. The scale at the top represents the genetic distance between the isolates..](1121-2233-54-24-g001){#F1}

MRPA isolates were detected in all clusters (except A) while pan-resistant isolates were recovered only in cluster C.

Cluster B and C was seen during the study period (4 seasons) ([Fig. 2](#F2){ref-type="fig"}). Cluster A was introduced during summer and remained present during the rest of the study. During the autumn, one patient appeared in cluster D and E. However, cluster D emerged in the third season, detection of this cluster during the winter did not occur.

![Distribution of different clusters during 2010.](1121-2233-54-24-g002){#F2}

In our study, 15 unique antibiogram patterns obtained from all isolates ([Tab. II](#T2){ref-type="table"}). Most of the isolates were resistant to antipseudomonal oxyimino-b-lactams. The highest percentage of susceptibility was seen in aminoglycosides (71%) followed by piperacillin-tazobactam (67%), imipenem (63%), ciprofloxacin (59%), and meropenem (55%). Different antibiogram patterns were displayed in a number of isolates even with ≥ 95% similarity.

###### 

Antibiogram patterns of 49 *P. aeruginosa* isolates.

  Pattern number   Isolates[^\*^](#T2FN2){ref-type="table-fn"}   CF   FEP   CP   MEM   CAZ   PTZ   IMP   GM   AM
  ---------------- --------------------------------------------- ---- ----- ---- ----- ----- ----- ----- ---- ----
  1                18b                                           S    S     S    S     S     S     S     S    S
  2                15,18a                                        S    S     S    S     R     S     S     S    S
  3                2a,12,14b,17b,17c,21,23,35a                   R    S     S    S     S     S     S     S    S
  4                10b,11,14a                                    R    S     S    S     R     S     S     S    S
  5                28a                                           S    S     S    R     S     S     S     R    S
  6                7,27a,27c                                     R    R     S    S     S     S     S     S    S
  7                8,10a,16,19a,27b,31                           R    R     S    S     R     S     S     S    S
  8                9,30                                          R    R     S    R     R     S     S     S    S
  9                33                                            R    R     R    R     R     S     S     S    S
  10               17a,36                                        R    R     S    R     R     R     S     S    S
  11               2c,10b,28c                                    R    R     R    S     R     S     R     S    S
  12               1,17d,19c                                     R    R     R    R     R     R     S     S    S
  13               28b                                           R    R     S    S     R     S     R     R    R
  14               19b,24                                        R    R     R    R     R     S     R     R    R
  15               2b,5,6,20,22,25,26,29,32,34,35b               R    R     R    R     R     R     R     R    R

CF, Cephalothin; FEP, Cefepime; CP, Ciprofloxacin; MEM, Meropenem; CAZ, Ceftazidime; PTZ, Piperacillin-tazobactam; IMP, Imipenem; GM, Gentamycin; AM, Amikacin

Isolate number of 26 to 36 belongs to CF patients

Discussion {#S4}
==========

Our hospital is a tertiary referral center in which the ICU setting includes mixed patients such as CF patients and transmission of *P. aeruginosa* strains between CF and the other hospitalized patients in ICU is probable,Therefore genotyping of *P. aeruginosa* isolates seems to be essential to clarify our hospital epidemiology. The spread of infection from patients with CF is a definite risk in children\'s wards especially in ICU \[[@R12], [@R13]\]. In this study, molecular typing suggests cross-transmission between CF and non- CF patients. According to our results, infections were predominantly caused by strains with cluster B and C. presence of these patterns during the whole period of this study suggesting that these clones are adapted to our hospital. Cluster B was identified in 25 strains (51% of all typed isolates) and highly appeared in the first 3 months of 2010 and circulated until end of the study.

Our analysis demonstrated that CF isolates are genotypically closely related to non-CF isolates. The two major clusters (B and C) in our study were discovered in both patient populations that suggest probable occurrence of cross-infection between these patients.

Studies about *P. aeruginosa* cross-infection demonstrated controversy evidence of clonal spread in CF centers. Some studies have revealed convincing evidence of clonal spread at CF holiday camps or centers \[[@R14]-[@R18]\]. Another study at the Vancouver CF Centre did not represent any evidence of significant cross-infection with *P. aeruginosa* \[[@R19]\].

Emergence of MDR expect to become more prevalent in many hospitals \[[@R20], [@R21]\]. There is no doubt that cross-transmission plays an important epidemiological role in MRPA isolates \[[@R22], [@R23]\], so prevention of the acquisition of these isolates are essential due to limited therapeutic options and increased mortality \[[@R24]\]. On the other hand, prevalence of strains with resistance to all antimicrobial agents is a major risk for hospitalized patients especially in CF patients because of rare *P. aeruginosa* eradication and subsequently occurrence of chronic infection \[[@R25], [@R26]\].

*P. aeruginosa* has capacity to develop resistance to essentially antimicrobial agents \[[@R27]\] and may require treatment with less commonly used antibacterial agents such as colistin \[[@R04]\].

Our results support other studies \[[@R28]\] that mentioned aminoglycosides are clinically effective against *P. aeruginosa* isolates when administrated intravenously or by nebulization.

Finally, in our study the high prevalence of related or identical isolates in CF and non--CF patients can be due to transmission of particular dominant clones in ICU ward. This suggests cross-infection can occur between CF and non-CF patients. Therefore, enhanced infection-control including strict segregation policies, basic hygiene measures and continued microbiological surveillance may become necessary to prevent further spread of clonal strains.
